Clinical trials
Head of European Affairs Committee participates in meeting "Building a European Health Union"
The head of Senate's Committee on European Affairs, Angel Tilvar, says Romania is still "at the bottom of the European rankings" in terms of the percentage of GDP allocated to health or patients' access to innovative medicines. "Our country is still at the bottom of the European rankings in terms of the percentage of GDP allocated to health or patients' access to innovative medicines.
South Africa suspends vaccinations as worries grow over AstraZeneca shot
South Africa suspended the start of its AstraZeneca inoculation programme over concerns the shot does not work on a new variant, with WHO experts due to meet on Feb. 8 to discuss the vaccine already facing questions about its efficacy for over-65s.
More than 1.500 newly infected, 14 people died
In the last 24 hours, 7.510 samples were tested, and a total of 2.693.265 since the outbreak of the epidemic.
Currently, 3.877 people are hospitalized, and there are 135 patients on the respirator.
So far, 4.126 people have died in Serbia, death rate amounting to 1.01 percent.
Blick: Serbia first in Europe in vaccination
- Read more about More than 1.500 newly infected, 14 people died
- Log in to post comments
CNCAV: Eighth tranche of Pfizer BioNTech vaccine to arrive in Romania on Monday
The National COVID-19 Vaccination Coordination Committee (CNCAV) announces that the eighth tranche of Pfizer BioNTech vaccine, of 163,800 doses, arrives in the country on Monday, by air, at Otopeni, Cluj-Napoca and Timisoara airports, informs CNCAV in a press release sent on Sunday to AGERPRES.
AstraZeneca jabs for ages 60-64 to start after Feb 12
Greece's National Vaccination Committee has unanimously approved the vaccine against the coronavirus produced by pharmaceuticals firm AstraZeneca for those aged 64 and younger.
More specifically, vaccinations for the 60-64 age group will start sometime after February 12, it was announced on Friday.
The online registration platform will open in the coming days.
Pfizer Drops India Vaccine Application after Regulator Seeks Local Trial
Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to meet the drug regulator's demand for a local safety and immunogenicity study.
Officially requested: Approve our vaccine, urgently
The company's request followed a report on January 29, which states that global clinical testing has shown that the effectiveness of this vaccine in preventing coronavirus infection amounts to 66 percent.
The vaccine, which is given in a single dose, could speed up delivery and simplify the U.S. immunization campaign, according to Reuters.
Number of people vaccinated tops 2.5 mln in Turkey
The number of people in Turkey who have received their first doses of a vaccine against the novel coronavirus crossed the 2.5 million mark as of Feb. 4, according to official figures.
In Turkey's mass vaccination campaign, under which health professionals are administering jabs of CoronaVac purchased from Chinese company Sinovac, immunization efforts are running smoothly.
- Read more about Number of people vaccinated tops 2.5 mln in Turkey
- Log in to post comments
CNCAV: Immunization with AstraZeneca vaccine - recommended for 18 to 55 age group
Immunization against COVID-19 with AstraZeneca vaccine is recommended for the 18 to 55 age group, with the possibility of increasing this range as new scientific data emerge, and the recommended time interval between the two doses is 8 weeks, the National COVID-19 Vaccination Coordination Committee (CNCAV) specified on Thursday.
EU names industry chief to ramp up vaccine output after AstraZeneca delays
European Union industry commissioner Thierry Breton was put in charge of a new vaccine production task force on Thursday after the EU executive came under fire over delays with deliveries of vaccines against the coronavirus.